messenger RNA (mRNA-1273 )vaccination
Showing 1 - 25 of 5,832
Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)
Completed
- Healthy Adult Volunteers
- ChAdOx1-nCov-19 (Astra-Zeneca)
- SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
-
Taipei City, X, TaiwanNational Taiwan University Hospital
Oct 16, 2022
Severe Exacerbation of Severe Acute Respiratory Syndrome
Active, not recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co. Ltd.,
Jun 5, 2023
Japan After Severe Acute Respiratory Syndrome Coronavirus 2
Not yet recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd
Jun 6, 2023
Japan of Shock and Anaphylaxis After Severe Acute Respiratory
Active, not recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd.
Jun 5, 2023
Chronic Kidney Diseases, COVID-19 Trial in Scarborough, Toronto (Pfizer-BioNTech COVID-19 Vaccine, MODERNA SARS-CoV-2 Vaccine)
Active, not recruiting
- Chronic Kidney Diseases
- COVID-19
- Pfizer-BioNTech COVID-19 Vaccine
- MODERNA SARS-CoV-2 Vaccine
-
Scarborough, Ontario, Canada
- +2 more
Aug 5, 2022
Corona Virus Disease 2019(COVID-19) Trial in Chengdu (0.3ml of mRNA vaccine)
Enrolling by invitation
- Corona Virus Disease 2019(COVID-19)
- 0.3ml of mRNA vaccine
-
Chengdu, ChinaWest China Second University Hospital
Oct 3, 2022
Myopericarditis After Messenger Ribonucleic Acid COVID-19
Recruiting
- Myopericarditis
- +4 more
- Pfizer-BioNTech mRNA COVID-19 vaccination
-
Copenhagen, DenmarkCopenhagen University Hospital, Rigshospitalet
Jan 16, 2022
COVID-19, Corona Virus Infection Trial in Ann Arbor (Pfizer-BioNTech mRNA COVID-19 vaccine, Moderna mRNA COVID-19 vaccine)
Recruiting
- COVID-19
- Corona Virus Infection
- Pfizer-BioNTech mRNA COVID-19 vaccine
- Moderna mRNA COVID-19 vaccine
-
Ann Arbor, MichiganUniversity of Michigan
Apr 23, 2022
COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)
Active, not recruiting
- COVID-19
- Ad26COVS1
- +3 more
-
Vienna, AustriaMedicial University of Vienna
Apr 12, 2022
Oncology Patients to Novel Coronavirus Vaccines (IROC)
Recruiting
- Cancer
- COVID-19 Vaccination
-
Carmel, Indiana
- +1 more
Aug 2, 2022
Herpes Zoster Trial in Tomball (HZ/su, Flu D-QIV, mRNA-1273)
Active, not recruiting
- Herpes Zoster
- HZ/su
- +2 more
-
Tomball, TexasGSK Investigational Site
Apr 8, 2022
Covid19, Kidney Diseases, Vaccine Response Impaired Trial in Netherlands (mRNA-1273, Ad26.COV2.S vaccine)
Completed
- Covid19
- +3 more
- mRNA-1273
- Ad26.COV2.S vaccine
-
Nijmegen, Gelderland, Netherlands
- +3 more
Mar 14, 2022
Vaccination; Infection, COVID-19 Trial in Leiden (solid microneedle skin patch, mRNA-1273, standard needle)
Recruiting
- Vaccination; Infection
- COVID-19
- solid microneedle skin patch
- +2 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 14, 2022
Papillomavirus Infections, Coronavirus Disease (COVID-19) Trial in United States (9vHPV Vaccine, mRNA-1273 Vaccine)
Recruiting
- Papillomavirus Infections
- Coronavirus Disease (COVID-19)
- 9vHPV Vaccine
- mRNA-1273 Vaccine
-
Phoenix, Arizona
- +37 more
Jan 18, 2023
Cancer Trial in Amsterdam, Groningen, Rotterdam (mRNA-1273 SARS-CoV-2 vaccine from Moderna)
Active, not recruiting
- Cancer
- mRNA-1273 SARS-CoV-2 vaccine from Moderna
-
Amsterdam, Netherlands
- +2 more
Mar 1, 2022
Breast Cancer Female, Early-stage Breast Cancer Trial in Jette (Trimix, Placebo)
Recruiting
- Breast Cancer Female
- Early-stage Breast Cancer
- Trimix
- Placebo
-
Jette, Brussel, BelgiumUZ Brussel
May 18, 2022
Adaptive Immune Response to COVID-19 Vaccination
Active, not recruiting
- SARS-CoV-2 Vaccination
- BNT162b2
- +2 more
-
Greifswald, MV, GermanyUniversity Medicine Greifswald
Mar 25, 2022
Covid19 Trial in Stockholm (Comirnaty (COVID-19, mRNA vaccine))
Active, not recruiting
- Covid19
- Comirnaty (COVID-19, mRNA vaccine)
-
Stockholm, Huddinge, SwedenKarolinska University Hospital
Sep 8, 2021
SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)
Active, not recruiting
- SARS-CoV-2
- mRNA-1273.211
- +6 more
-
Sacramento, California
- +22 more
Nov 16, 2022
COVID-19 Trial in United States (Ad26.COV2.S, BNT162b2, mRNA-1273)
Recruiting
- COVID-19
- Ad26.COV2.S
- +4 more
-
Atlanta, Georgia
- +11 more
Aug 11, 2022
SARS-CoV-2 Trial in United States (mRNA-1273, Placebo)
Recruiting
- SARS-CoV-2
- mRNA-1273
- +2 more
-
Banning, California
- +48 more
Jan 5, 2023
Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,
Recruiting
- Kidney Transplant Recipients
- Liver Transplant Recipients
- Pfizer-BioNTech Bivalent COVID-19 Vaccine
- +3 more
-
San Diego, California
- +14 more
Oct 31, 2022
Kidney Transplant Recipients Trial in Baltimore (mRNA-1273 vaccine (Pfizer/BioNTech), mRNA-1273 vaccine (Moderna))
Active, not recruiting
- Kidney Transplant Recipients
- mRNA-1273 vaccine (Pfizer/BioNTech)
- mRNA-1273 vaccine (Moderna)
-
Baltimore, MarylandJohns Hopkins Hospital
Oct 4, 2021
SARS-CoV-2 Trial in Atlanta, Seattle (mRNA-1273)
Active, not recruiting
- SARS-CoV-2
- mRNA-1273
-
Mesa, Arizona
- +14 more
Aug 31, 2022